Buy Proteon Therapeutics Stock | PRTO Stock Price & Latest News | Public
PRTO

Proteon Therapeutics

$0.00 (0.00%)Today

    About PRTO

    Proteon Therapeutics, Inc. engages in the research and development of biopharmaceutical products. It produces and commercializes vonapanitase for the treatment of renal and vascular disease. The company was founded by F. Nicholas Franano and William P. Whitaker in 2001 ...Read more

    Buy any stock with any amount of money.

    Download the App
    Download the app

    What Wall Street Thinks

    Earnings

    The value each share was expected to gain vs. the value that each share actually gained

    0
    -0.96
    -1.92
    -2.89
    Q4 2019
    Q1 2020
    Q2 2020
    Q3 2020

    Expected EPS
    Q3 2020

    -$1.07

    Actual EPS
    Q3 2020

    Stats

    Market Cap$98,83M
    Volume
    Price-to-Earnings Ratio
    Dividend Rate
    Dividend Yield
    1 Year High$67.08
    1 Year Low$8.80
    Open
    High
    Low

    Buy any stock with any amount of money.

    Download the App
    Download the app